Arnatar Therapeutics · 6 days ago
Director/Sr. Director, Finance and Accounting
Arnatar Therapeutics is seeking a Director/Senior Director for their Finance and Accounting function. This role involves leading finance processes, providing financial analyses for decision-making, and supporting business development efforts.
Biotechnology
Responsibilities
Create and implement an annual budgeting process, along with a process for updating the budget quarterly. This would also include evaluating the financial implications of alternative operating scenarios
Oversee payroll, reporting, external accountants, and financial audits
Provide monthly variance reporting on a department and corporate basis comparing actual financial performance with budget and understanding the key variance drivers
Develop and maintain the company’s long-range financial forecasts
Proactively look for opportunities to perform ad hoc financial analyses that provide key insights to support optimal decision-making
Contribute to board presentations and external corporate communications materials, including investor decks, earnings releases, SEC filings, etc
Qualification
Required
BS degree in business, finance, accounting, economics or related area is required
CPA
Prior Biotech, pharmaceutical, and/or biopharma experience
Ability to work on-site at our San Diego office
Preferred
MBA or Masters in accounting or finance
5-10 years of relevant professional experience, ideally leading FP&A within a biotech company
Investment banking experience is helpful
Must possess a strong knowledge of US GAAP and Sarbanes-Oxley compliance
Strong Excel modelling skills and adept at using PowerPoint
Demonstrated initiative to create and drive implementation of new processes
Effective cross-functional collaborator with strong communication skills, comfortable multi-tasking, and capable of operating in a matrixed, fast-paced biotech environment
High attention to detail balanced with the ability to think strategically
Company
Arnatar Therapeutics
We are a San Diego-based RNA company pioneering novel therapeutics that aim to address high unmet medical needs in cardiovascular, metabolic, rare liver, and rare kidney diseases.
Funding
Current Stage
Early StageCompany data provided by crunchbase